Acetylcholine-induced vasodilation in the perfused kidney of the streptozotocin-induced diabetic rat: Role of prostacyclin

Journal of Smooth Muscle Research

Volumn 42, Issue 5, 2006, Pages 159-170

  Kamata, Katsuo ^a   Hosokawa, Masao ^a   Matsumoto, Takayuki ^a   Kobayashi, Tsuneo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Acethylcholine; Endothelium; Kidney; Perfusion pressure; Prostacyclin; Rat

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; FUREGRELATE; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; STREPTOZOCIN; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; KIDNEY PERFUSION; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; VASODILATATION;

ACETYLCHOLINE; ANIMALS; BLOOD VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; EPOPROSTENOL; KIDNEY; PERFUSION; RATS; RATS, WISTAR; STREPTOZOCIN; VASODILATION; VASODILATOR AGENTS;

EID: 33845498158     PISSN: 09168737     EISSN: None     Source Type: Journal    
DOI: 10.1540/jsmr.42.159     Document Type: Article

References (65)

1. Alabadi, J.A., Miranda, F.J., Llorens, S., Ruiz de Apodaca, R.F., Centeno, J.M. and Alborch, E. (2001). Diabetes potentiates acetylcholine-induced relaxation in rabbit renal arteries. Eur. J. Pharmacol. 415: 225-232.
2. Anderson, S. and Vora, J.P. (1995). Current concepts of renal hemodynamics in diabetes. J. Diabetes Complications 9: 304-307.
3. Beenen, O.H., Mathy, M.J., Pfaffendorf, M. and van Zwieten, P.A. (1996). Vascular responsiveness in isolated perfused kidneys of diabetic hypertensive rats. J. Hypertens. 14: 1125-1130.
4. Bhardwaj, R. and Moore, P.K. (1988). Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J. Pharm. Pharmacol. 40: 739-742.
5. Blanco-Rivero, J., Cachofeiro, V., Lahera, V., Aras-Lopez, R., Marquez-Rodas, I., Salaices, M., Xavier, F.E., Ferrer, M. and Balfagon, G. (2005). Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension 46: 107-112.
6. Bolla, M., You, D., Loufrani, L., Levy, B.I., Levy-Toledano, S., Habib, A. and Henrion, D. (2004). Cyclooxygenase involvement in thromboxane-dependent contraction in rat mesenteric resistance arteries. Hypertension 43: 1264-1269.
7. Bryan, R.M.Jr., You, J., Golding, E.M. and Marrelli, S.P. (2005). Endothelium-derived hyperpolarizing factor: a cousin to nitric oxide and prostacyclin. Anesthesiol. 102: 1261-1277.
8. Busse, R., Edwards, G., Feletou, M., Fleming, I., Vanhoutte, P.M. and Weston, A.H. (2002). EDHF: bringing the concepts together. Trends Pharmacol. Sci. 23: 374-380.
9. Chang, W.P., Dimitriadis, E., Allen, T., Dunlop, M.E., Cooper, M. and Larkins, R.G. (1991). The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Diabetologia 34: 225-231.
10. Chen, G., Suzuki, H. and Weston, A.H. (1988). Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol. 95: 1165-1174.
11. Cohen, R.A. (1995). The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog. Cardiovasc. Dis. 38: 105-128.
12. Dai, F.X., Diederich, A., Skopec, J. and Diederich, D. (1993). Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxidases and free radicals. J. Am. Soc. Nephrol. 4: 1327-1336.
13. De Vriese, A.S., Van de Voorde, J., Blom, H.J., Vanhoutte, P.M., Verbeke, M. and Lameire, N.H. (2000a). The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin- induced diabetic rats is restored by 5-methyltetrahydrogolate. Diabetologia 43: 1116-1125.
14. De Vriese, A.S., Verbeuren, T.J., Van de Voorde, J., Lameire, N.H. and Vanhoutte, P.M. (2000b). Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130: 963-974.
15. Fitzgerald, S.M., Kemp-Harper, B.K., Tare, M. and Parkington, H.C. (2005). Role of endothelium-derived hyperpolarizing factor in endothelial dysfunction during diabetes. Clin. Exp. Pharmacol. Physiol. 32: 482-487.
16. Fukao, M., Hattori, Y., Kanno, M., Sakuma, I. and Kitabatake, A. (1997). Alteration in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 121: 1383-1391.
17. Furchgott, R.F. and Zawadzki, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
18. Garcia, V.M., Ochoa, J.E. and Elias, M.M. (1999). Effect of early stage of experimental diabetes on vascular functions in isolated perfused kidneys. J. Auton. Pharmacol. 19: 97-103.
19. Gebremedhin, D., Koltai, M.Z., Pogatsa, G., Magyar, K. and Hadhazy, P. (1989). Altered responsiveness of diabetic dog renal arteries to acetylcholine and phenylephrine: role of endothelium. Pharmacology 38: 177-184.
20. Hayashi, K., Epstein, M., Loutzenhiser, R. and Forster, H. (1992). Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J. Am. Soc. Nephrol. 2: 1578-1586.
21. Hernantz, R., Alonso, M.J., Briones, A.M., Vila, E., Simonsen, U. and Salaices, M. (2003). Mechanisms involved in the early increase of serotonin contraction evoked by endotoxin in rat middle cerebral arteries. Br. J. Pharmacol. 140: 671-680.
22. Ito, S., Johnson, C.S. and Carretero, O.A. (1991). Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J. Clin. Invest. 87: 1656-1663.
23. Kamata, K. and Hayashi, T. (1999). Effects of chronic treatment with the spontaneous nitric oxide releaser FK409 on vascular responses in established streptozotocin-induced diabetic rat. Res. Commun. Mol. Pathol. Pharmacol. 103: 275-294.
24. Kamata, K. and Hosokawa, M. (1997a). Characteristics of vasodilatation induced by cyclopiazonic acid in the rat perfused kidney. Res. Commun. Mol. Pathol. Pharmacol. 96: 147-156.
25. Kamata, K. and Hosokawa, M. (1997b). Endothelial dysfunction in the perfused kidney from the streptozotocin-induced diabetic rat. Res. Commun. Mol. Pathol. Pharmacol. 96: 57-70.
26. Kamata, K. and Kobayashi, T. (1996). Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br. J. Pharmacol. 119: 583-589.
27. Kamata, K., Kobayashi, T., Matsumoto, T., Kanie, N., Oda, S., Kaneda, A. and Sugiura, M. (2005). Effects of chronic administration of fruit extract (Citrus unshiu Marc) on endothelial dysfunction in streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 28: 267-270.
28. Kamata, K., Miyata, N. and Kasuya, Y. (1989). Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 97: 614-618.
29. Kamata, K. and Mizutani, K. (1999). Changes in angiotensin converting enzyme activity in the renal vascular bed of streptozotocin-induced diabetic rat. Res. Commun. Mol. Pathol. Pharmacol. 104: 181-192.
30. Kamata, K., Nakajima, M. and Sugiura, M. (1999). Effects of superoxide dismutase on the acetylcholine-induced relaxation response in cholesterol-fed and streptozotocin-induced diabetic mice. J. Smooth Muscle Res. 35: 33-46.
31. Kamata, K. and Yamashita, K. (1999). Insulin resistance and impaired endothelium-dependent renal vasodilatation in fructose-fed hypertensive rats. Res. Commun. Mol. Pathol. Pharmacol. 103: 195-210.
32. Kobayashi, T., Matsumoto, T. and Kamata, K. (2000). Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats. Br. J. Pharmacol. 131: 231-238.
33. Kobayashi, T., Matsumoto, T. and Kamata, K. (2005). The PI3-K/Akt pathway: roles related to alterations in vasomotor responses in diabetic models. J. Smooth Muscle Res. 41: 283-302.
34. Kobayashi, T., Taguchi, K., Yasuhiro, T., Matsumoto, T. and Kamata, K. (2004). Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. Hypertension 44: 956-962.
35. Kopecky, R.T. and Schroeder, E.T. (1988). Glomerular prostaglandin production in diabetic rats with renovascular hypertension. Kidney Int. 33: 1100-1106.
36. Lerman, L.O. and Rodriguez-Porcel, M. (2001). Functional assessment of the circulation of the single kidney. Hypertension 38: 625-629.
37. Majid, D.S. and Navar, L.G. (1992). Suppression of blood flow autoregulation plateau during nitric oxide blockade in canine kidney. Am. J. Physiol. 262: F40-F46.
38. Makino, A., Ohuchi, K. and Kamata, K. (2000). Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. Br. J. Pharmacol. 130: 549-556.
39. Matsumoto, T., Kobayashi, T. and Kamata, K. (2003a). Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats. Am. J. Physiol. 285: H283-H291.
40. Matsumoto, T., Kobayashi, T. and Kamata, K. (2003b). Phosphodiesterases in the vascular system. J. Smooth Muscle Res. 39: 67-86.
41. Matsumoto, T., Kobayashi, T. and Kamata, K (2006a). A therapeutic target for microvascular complications in diabetes: endothelium-derived hyperpolarizing factor. Curr. Cardiol. Rev. 2: 185-191.
42. Matsumoto, T., Miyamori, K., Kobayashi, T. and Kamata, K (2006b). Apocynin normalizes hyperreactivity to phenylephrine in mesenteric arteries from cholesterol-fed mice by improving endothelium-derived hyperpolarizing factor response. Free Radic. Biol. Med. 41: 1289-1303.
43. Matsumoto, T., Oda, S.I., Kobayashi, T. and Kamata, K. (2004a). Flow-induced endothelium-dependent vasoreactivity in rat mesenteric arterial bed. J. Smooth Muscle Res. 40: 1-14.
44. Matsumoto, T., Yoshiyama, S., Wakabayashi, K., Kobayashi, T. and Kamata, K. (2004b). Effects of chronic insulin on endothelial dysfunction of basilar arteries from established streptozotocin-diabetic rats. Eur. J. Pharmacol. 504: 119-127.
45. Matsumoto, T., Kobayashi, T., Wakabayashi, K. and Kamata, K. (2005). Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic rats. Am. J. Physiol. 289: H1933-H1940.
46. Mayhan, W.G., Simmons, L.K. and Sharpe, G.M. (1991). Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 260: H319-H326.
47. Moncada, S., Herman, A.G., Higgs, E.A. and Vane, J.R. (1977). Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb. Res. 11: 323-344.
48. Nangle, M.R., Gibson, T.M., Cotter, M.A. and Cameron, N.E. (2006). Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Planata Med. 72: 494-500.
49. Pieper, G.M. (1998). Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31: 1047-1060.
50. Poston, L. and Taylor, P.D. (1995). Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin. Sci. 88: 251-252.
51. Salom, M.G., Lahera, V. and Romero, J.C. (1991). Role of prostaglandins and endothelium-derived relaxing factor on the renal response to acetylcholine. Am. J. Physiol. 260: F145-F149.
52. Schambelan, M., Blake, S., Sraer, J., Bens, M., Nivez, M.P. and Wahbe, F. (1985). Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J. Clin. Invest. 75: 404-412.
53. 2 as an endothelium-derived contracting factor in diabetic state. Diabetes 42: 1246-1252.
54. Sowers, J.R. and Epstein, M. (1995). Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 26: 869-879.
55. Takano, H., Dora, K.A. and Garland, C.J. (2005). Spreading vasodilatation in resistance arteries. J. Smooth Muscle Res. 41: 303-311.
56. Tanaka, Y., Koike, K. and Toro, L. (2004). MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms. J. Smooth Muscle Res. 40: 125-153.
57. Tesfamariam, B., Jakubowski, J.A. and Cohen, R.A. (1989). Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am. J. Physiol. 257: H1327-H1333.
58. Thomson, S.C., Vallon, V. and Blantz, R.C. (2004). Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am. J. Physiol. 286: F8-F15.
59. Triggle, C.R., Hollenberg, M., Anderson, T.J., Ding, H., Jiang, Y., Ceroni, L., Wiehler, W.B., Ng, E.S., Ellis, A., Andrews, K., McGuire, J.J. and Pannirselvam, M. (2003). The endothelium in health and disease-a target for therapeutic intervention. J. Smooth Muscle Res. 39: 249-267.
60. Vanhoutte, P.M., Feletou, M. and Taddei, S. (2005). Endothelium-dependent contractions in hypertension. Br. J. Pharmacol. 144: 449-458.
61. Vila, J.M., Medina, P., Segarra, G., Aldasoro, M., Noguera, I. and Lluch, S. (2001). Endothelin-1-induced potentiation of adrenergic responses in the rabbit pulmonary artery: role of thromboxane A(2). Eur. J. Pharmacol. 413: 247-254.
62. Vizioli, E.O., Spadin, M.D., Correa, F.M., Viaro, F., Evora, P.R. and Chies, A.B. (2005). Acetylcholine-induced aortic relaxation studied in sulbutamol treated rats. J. Smooth Muscle Res. 41: 271-281.
63. Wolf, G., Chen, S. and Ziyadeh, F.N. (2005). From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54: 1626-1634.
64. Yamamoto, Y. and Suzuki, H. (2005). Dependency of endothelial cell function on vascular smooth muscle cells in guinea-pig mesenteric arteries and arterioles. J. Smooth Muscle Res. 41: 77-85.
65. Yousif, M.H. (2003). Diabetes differentially modulated receptor- and non-receptor-mediated relaxation in rat renal artery. Pharmacol. Res. 48: 295-300.